4//SEC Filing
Androski Lindsay 4
Accession 0001104659-24-109524
CIK 0001035354other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:01 PM ET
Size
5.3 KB
Accession
0001104659-24-109524
Insider Transaction Report
Form 4
Androski Lindsay
Director
Transactions
- Award
Common Stock
2024-10-16+12,000→ 12,000 total
Footnotes (1)
- [F1]This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001936604
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:01 PM ET
- Size
- 5.3 KB